Abstract
When groups of 10 Spontaneously Hypertensive Rats (SHR) were fed diets containing either 1% w/w regular garlic (Allium sativum) (AS) or 1% w/w wild garlic (Allium ursinum) (AU) for 45days, the final mean systolic blood pressure (SBP) was reduced significantly compared to control (C) (C 189; AS 175; Au 173 mm Hg). Compared to C, body weight and circulating glucose and triglyceride levels were not significantly different; but circulating insulin was significantly higher (C 23.6; AS33.9; AU 29.5 uIU/dl), and total cholesterol was significantly lower (C 133; AS 115; AU117 mg/dl) in the two groups consuming AS or AU. HDL rose in the two garlic groups, but the differences from C were statistically significant only for the AU group. In a second study, the effects of a lower dose of dietary AS and AU (0.1% w/w) on SBP and various blood chemistries were compared head-to-head in 80SHR — 40 control and 40 test rats. Both AS and AU decreased SBP significantly compared to a control group of 10 SHR followed simultaneously. However, AU at this lower concentration produced a significantly greater SBP-lowering effect compared to the AS group. In addition, AU decreased total cholesterol significantly and tended to increase HDL compared to AS. Accordingly, the results suggest that AU has a greater therapeutic benefit compared to AS at a given concentration.
This is a preview of subscription content,
to check access.Similar content being viewed by others
References
Chopra RN, Chopra IC, Handa KL, Kapur LD. Indigenous Drugs of India, Allium sativum, Second Edition. Calcutta: Dhru and Sons, 1951, p. 251.
Kendler BS. Garlic (Allium sativum) and Onion (Allium cepa): a review of their relationship to cardiovascular disease. Preventive Med 1987; 16: 670–685.
Knipschild KP, Ter Riet G. Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Br. J Clin Pharmac 1989; 28: 535–544.
Murray MT. Cardiovascular effects of commercial garlic preparations. Am J Nat Med 1995; 2: 5–7.
Dausch JG, Nixon DW. Garlic: a review of its relationship to malignant disease. Prev Med 1990; 19: 346–361.
Han J. Highlights of the cancer chemoprevention studies in China. Prev Med 1993; 22: 712–722.
Lerner DJ, Hulley SB. Does eating garlic lower cholesterol? Ann Intern Med (letter) 1994; 120: 969.
Harenberg J, Giese C, Zimmerman R. Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia. Atherosclerosis 1988; 74: 247–249.
Chi MS, Koh ET, Stewart TJ. Effects of garlic on lipid metabolism in rats fed cholesterol or lard. J Nutr 1982; 112: 241–248.
Silagy C, Neil A. Garlic as a lipid lowering agent - a meta analysis. J Roy Coll Physic 1994; 28: 39–45.
Yeh YY, Yeh SM. Garlic reduces plasma lipids by inhibiting hepatic cholesterol and triacylglycerol synthesis. Lipids 1994; 29: 189–193.
Heinle H, Betz E. Effects of dietary garlic supplementation in a rat model of atherosclerosis. Drug Res 1994; 44: 614–617.
Kiesewetter H, Jung F, Pindur G, Jung EM, Mrowietz C, Wenzel E. Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors. Int J of Clin Pharmacol, Therapy and Toxicology. 1991; 29: 151–155.
Mansell P, Reckless JPD. Effects on serum lipids, blood pressure, coagulation, platelet aggregation, and vasodilation. Br Med J 1991; 303: 379–380.
Kiesewetter H, Jung F, Mrowietz C, Koscielny J, Wenzel E. Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack. Eur J Clin Pharmacol 1993; 45: 333–336.
Chang MLW, Johnson MA. Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J Nutr 1980; 110: 931–936.
Ernst E. Cardiovascular effects of garlic (Allium sativum): a review. Pharmacotherapeutica 1987; 5: 83–89.
Auer W, Eiber A, Hertkorn E, Hoehfeld E, Koihrle U, Lorenz A, Mader F, Merx W, Otto G, Schmid-Otto B, Taubenheim H. Hypertension and hyperlipidaemia: garlic helps in mild cases. Br J Clin Prac 1990; 69: 3–6.
McMahon FG, Vargas R. Can garlic lower blood pressure? A pilot study. Pharmacotherapy 1993; 13: 406–407.
Clouatre D. European Wild Garlic. The Better Garlic. San Francisco CA: Pax Publishing, 1995, pp. 1–38.
Chandorkar AG, Jain PK. Analysis of hypotensive action of Allium sativum (Garlic). Ind J Physiol Pharmac 1973; 17: 132–133.
Banerjee AK. Effect of aqueous extract of garlic on arterial blood pressure of normotensive and hypertensive rats. Artery 1976; 2: 369–373.
Reuter HD, Sendl A. Allium sativum and Allium ursinum: Chemistry, pharmacology and medicinal applications. Economic and Medicinal Plant Research 1994; 6: 55–113.
Mutsch-Eckner M, Meier B, Wright AD, Sticher O. Gammaglutamyl peptides from allium sativum bulbs. Phytochemistry 1992; 31: 2389–2391.
Meunier MT, Villie F, Jonadet M, Bastide J, Bastide P. Inhibition of angiotensin I converting enzyme by flavianolic compounds: in vitro and in vivo studies. Planta medica 1986; 53: 12–15.
Sendl A, Elbl G, Steinke B, Redl K, Breu W, Wagner H. Comparative pharmacological investigations of Allium ursinum and Allium sativum. Plant Medica 1992; 58: 1–7.
Wagner H, Elbl G, Lotter H, Guinea M. Evaluation of natural products as inhibitors of angiotension I - converting enzyme (ACE). Pharmacol Lett 1991; 1: 15–18.
Rietz B, Isensee H, Strobach H, Makdessi S, Jacob R. Cardioprotective actions of wild garlic (Allium ursinum) in ischemia and reperfusion. Mol Cell Biochem 1993; 119: 143–150.
Torok B, Belagye J, Rietz B, Jacob R. Effectiveness of garlic on the radical activity in radical generating systems. Drug Res 1994; 44: 608–611.
Jung EM, Jung F, Mrowietz H, Kieswetter H, Pidndur G, Wenzel E. Influence of garlic powder on cutaneous microcirculation. Drug Res 1991; 41: 626–630.
Jung F, Jung EM, Mrowietz C, Kiesewetter H, Wenzel E. Influence of garlic powder on cutaneous microcirculation; a randomised, placebo-controlled, double-blind, crossover study in apparently healthy subjects. Br J Clin Practice 1990; 44(suppl 69): 30–35.
Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rat. Jap Circ J: 1963; 27: 282–293.
Bunag RD. Validation in awake rats of a tail-cuff method measuring systolic pressure. J Appl Physiol 1973; 34: 279–282.
Whelton PK, Klag MJ. Epidemiology of hypertension. In: Applegate WB, ed. Clinics in Geriatric Medicine: Hypertension. Philadelphia: WB Saunders, 1989, pp. 639–656.
DeFronzo RA, Ferinimmi E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–194.
Das I, Khan NS, Soornanna SSR. Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic application. Current Medical Research and Opinion 1994; 13: 257–263.
Torok B, Belagyi J, Rietz B, Jacob R. Effectiveness of garlic on the radical activity in radical generating systems. Arzneim-Forsch/Drug Res 1994; 44: 608–611.
Sendl A, Schliack M, Losu R, Stanislaus F, Wagner H. Inhibition of cholesterol synthesis in vitro by extracts and isolated compunds prepared from garlic and wild garlic. Atherosclerosis 1992; 94: 79–85.
Jain RC, Vyas CR. Garlic and alloxan-induced diabetic rabbits. Am J Clin Nutr 1984; 28: 684–685.
Sodimu O, Joseph PK, Augusti KT. Certain biological effects of garlic oil on rats maintained on high fat-high cholesterol diet. Experientia 1984; 40: 78–80.
Aouadi R, Aouidet A, Elkadhi A, Ben Rayana C, Jaafoura H, Tritar B, Nagati K. Effect of fresh garlic (Allium sativum) on lipid metabolism in male rats. Nutr Res 2000; 20: 273–280.
Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chem. Report 1966; 50: 219–239.
Pedraza-Chaverri J, Tapia E, Medinal-Campos ON, de los Angeles Granados M, Franco M. Garlic prevents hypertension induced by chronic inhibition of nitric oxide synthesis. Life Sci 1998; 62: PL 71–77.
Das I, Khan NS, Soornanna SSR. Potent activation of nitric oxide synthase by garlic: a basis for its therapeutic application. Current Medical Research and Opinion 1994; 13: 257–263.
Torok B, Belagyi J, Rietz B, Jacob R. Effectiveness of garlic on the radical activity in radical generating systems. Arzneim-Forsch/Drug Res 1994; 44: 608–611.
Mohamadi A, Jarrell ST, Shi S-J, Andrawis NS, Myers A, Clouatre D, Preuss HG. Effects of wild versus cultivated garlic on blood pressure and other parameters in hypertensive rats. Heat Disease 2000; 2: 3–9.
Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 2000; 133: 420–429.
Bordia A, Verma SK, Srivastava KC. Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids. 1998; 58: 257–263.
Rahman K, Billington D. Dietary supplementation with aged garlic extract inhibits ADP-induced platelet aggregation in humans. J Nutr 2000; 130: 2662–2665.
Tobian L. Human essential hypertension: implications of animal studies. Ann Int Med 1983; 98: 729–734.
Preuss HG. Interaction of genetics and nutrition on hypertension. J Am Coll Nutr 1997; 16: 296–305.
Freis. ED. Salt, volume, and the prevention of hypertension. Circulation. 1976; 53: 383–387.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Preuss, H.G., Clouatre, D., Mohamadi, A. et al. Wild garlic has a greater effect than regular garlic on blood pressure and blood chemistries of rats. Int Urol Nephrol 32, 525–530 (2001). https://doi.org/10.1023/A:1014417526290
Issue Date:
DOI: https://doi.org/10.1023/A:1014417526290